Wednesday 8 July 2015

Extending anticoagulation duration cuts risk of VTE recurrence

But benefit disappears once warfarin is stopped, even after extra 18 months’ therapy

Related items from OnMedica

Self-monitoring cuts warfarin clot risk
Aspirin as effective as warfarin for heart patients
NOACs instead of warfarin
High clot risk for women admitted to hospital during pregnancy
Time to rethink 4.5h window for alteplase after stroke
via OnMedica News Read More Here..

No comments:

Post a Comment